Inverse relationship between polygenic risk burden and age of onset of autoimmune vitiligo.
Where this comes from
- Record sourced from PubMed, PMID 39419028.
- Also identified by DOI 10.1016/j.ajhg.2024.09.007 and PMC identifier 11568747.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vitiligo is a common autoimmune disease characterized by patches of depigmented skin and overlying hair due to destruction of melanocytes in the involved regions. We investigated the relationship between vitiligo risk and vitiligo age of onset (AOO) using a vitiligo polygenic risk score that incorporated the most significant SNPs from genome-wide association studies. We find that vitiligo genetic risk and AOO are strongly inversely correlated; subjects with higher common-variant polygenic risk tend to develop vitiligo at an earlier age. Nevertheless, the correlation is not simple. In individuals who carry a single high-risk major histocompatibility complex class II haplotype, the effect of additional polygenic risk on vitiligo AOO is reduced. Particularly among those with early-AOO vitiligo (onset ≤12 years of age), genetic risk can reflect contributions from high common-variant burden but also rare variants of high effect and sometimes both. While the heritability of vitiligo is relatively high, and we here show that genetic risk factors predict vitiligo AOO, vitiligo is never congenital, and thus environmental triggers also play an important role in disease onset.
Medical subject headings
- Vitiligo
- Age of Onset
- Multifactorial Inheritance
- Genome-Wide Association Study
- Polymorphism, Single Nucleotide
- Autoimmune Diseases
- Genetic Predisposition to Disease